Vanguard Group Inc Neogenomics Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 14,130,761 shares of NEO stock, worth $85.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,130,761
Previous 14,257,116
0.89%
Holding current value
$85.9 Million
Previous $135 Million
23.65%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.1MPut Options Held
296K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$45.2 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$41.6 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$31.1 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.81MShares$29.2 Million0.04% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...